| ASSET | YEAR | % RETURN |
|---|---|---|
Onto Innovation (ONTO) | 1995 | 1,080% |
Biogen (BIIB) | 1995 | 791.39% |
Semtech (SMTC) | 1995 | 642.91% |
Regeneron Pharmaceuticals (REGN) | 1995 | 277.77% |
Gilead Sciences (GILD) | 1995 | 236.81% |
Ionis Pharmaceuticals (IONS) | 1995 | 228.13% |
Cadence Design Systems (CDNS) | 1995 | 207.32% |
Coherent (COHR) | 1995 | 191.55% |
Boston Scientific (BSX) | 1995 | 187.59% |
Cognex (CGNX) | 1995 | 169.89% |
Arrowhead Pharmaceuticals (ARWR) | 1995 | 166.67% |
IDEXX Laboratories (IDXX) | 1995 | 164.78% |
Jabil Circuit (JBL) | 1995 | 164.66% |
Viavi Solutions (VIAV) | 1995 | 146.56% |
Gartner (IT) | 1995 | 145.51% |
Intuit (INTU) | 1995 | 135.47% |
Ross Stores (ROST) | 1995 | 135.38% |
Cigna (CI) | 1995 | 133.49% |
NetApp (NTAP) | 1995 | 132.63% |
Toll Brothers (TOL) | 1995 | 130% |
Heico (HEI) | 1995 | 127% |
Dycom Industries (DY) | 1995 | 125% |
Skyworks Solutions (SWKS) | 1995 | 121.57% |
Cisco Systems (CSCO) | 1995 | 113.22% |
Nike (NKE) | 1995 | 109.39% |
Large-cap stocks are treated as having a market cap of $10B+.